Does serum 25 hydroxy vitamin D level play a role in COPD?

El-Shafey, Basem I.; El-Srougy, Hesham A.

doi:10.1016/j.ejcdt.2013.09.021

Cited by 4 publications

(2 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…level and FEV 1 % and FVC% (P=0.030 and 0.008, respectively) which is in agreement with Said and Abd-Elnaeem [10] and Persson et al [17] who found that there was a significant association between vitamin D levels and FEV 1 % predicted in COPD patients. This finding was also in agreement with Janssens et al [3] and El-Shafey et al [21].…”

Section: Figuresupporting

confidence: 92%

Does vitamin D deficiency worsen the clinical and functional parameters of stable chronic obstructive pulmonary disease patients?

et al. 2019

View full text Add to dashboard Cite

show abstract

Section: Figuresupporting

confidence: 92%

Does vitamin D deficiency worsen the clinical and functional parameters of stable chronic obstructive pulmonary disease patients?

et al. 2019

View full text Add to dashboard Cite

show abstract

“…This finding was in accordance with Janssens et al [9] who found that 25-OHD serum levels were correlated significantly with FEV1 in the COPD subgroup (r = 0.28, P < 0.0001) with no correlation with FEV1 in the subgroup of healthy controls. EL-Shafey and EL-Srougy [21] found also that a significant correlation was found between serum 25-OHD and FEV1 (r = 0.896, P = 0.001).…”

Section: Discussionmentioning

confidence: 81%

Vitamin D and chronic obstructive pulmonary disease

Said

Abd-Elnaeem

2015

Egyptian Journal of Chest Diseases and Tuberculosis

View full text Add to dashboard Cite

Background: Evidence is increasing that suggests an expanded role of vitamin D in health outcomes apart from its classic actions on the bone and calcium homeostasis. Vitamin D deficiency has been associated with some chronic respiratory illnesses; one of them is chronic obstructive pulmonary disease (COPD).Objective: This study was designed to detect vitamin D level among stable COPD patients. The effect of vitamin D supplements (200,000 IU monthly for 6 months) with regular therapy of COPD on COPD outcomes was also evaluated.Patients and methods: Pulmonary function test (PFT), COPD assessment test (CAT), 6 min walk test (6MWT), serum 25-hydroxyvitamin D (25-OHD) and ionized calcium were performed on 61 COPD patients (50 males and 11 females, mean age 61.1 years). PFT and clinical assessment were carried out at the start and completion of 6 month treatment among those with vitamin D deficiency. Twenty healthy age-matched and sex matched volunteers were also studied as a control group.Results: The distribution of vitamin D status including vitamin D deficiency, vitamin D insufficiency and vitamin D sufficiency was 16.4%, 34.4% and 49.2% respectively among COPD patients.There was no significant improvement of 6MWT, CAT score and PFT among those treated with vitamin D supplements in addition to standard therapy of COPD.Conclusion: Low serum level of vitamin D was less common among COPD patients than other studies and correlates with severity of COPD. 6 month supplementation of standard treatment with 200,000 IU monthly of vitamin D did not provide additional clinical benefit among COPD patients.

show abstract

Chronic Obstructive Pulmonary Disease: A 2019 Evidence Analysis Center Evidence-Based Practice Guideline

Hanson

Bowser

Frankenfield

et al. 2021

Journal of the Academy of Nutrition and Dietetics

View full text Add to dashboard Cite

Chronic obstructive pulmonary disease (COPD) is a progressive lung disorder in which patients are at high risk for both pulmonary and systemic complications of their disease. Medical nutrition therapy by a registered dietitian nutritionist can be an integral component of lifestyle treatment targeted at maintaining and improving outcomes, such as lung function, mortality, and quality of life. The Academy of Nutrition and Dietetics (Academy) convened an expert workgroup to conduct a systematic review to update the COPD Evidence-Based Nutrition Practice Guideline. This publication outlines the Academy's Evidence Analysis Library methods used to complete the systematic review and guideline and examines the recommendations and supporting evidence. A total of 14 recommendations were developed based on evidence from eight conclusions. Using the Nutrition Care Process as a framework for practice, recommendations rated as strong included assessing and monitoring and evaluating body weight and medical nutrition therapy by a registered dietitian nutritionist. Weak recommendations included predicting resting and total energy expenditure. All other recommendations were rated as fair. These included individualizing the calorie prescription and macronutrient composition of the diet; assessing and monitoring and evaluating energy intake, serum 25-hydroxyvitamin D levels, and frequency of exacerbations; and determining need for vitamin D supplementation. Fewer than one-third of the systematic review's conclusions could be used to support the recommendations due to conflicting results or limited or no evidence available. The Evidence Analysis Library 2019 COPD Evidence-Based Nutrition Practice Guideline is a valuable resource for registered dietitian nutritionists and other health care professionals caring for those with COPD.

show abstract

Does serum 25 hydroxy vitamin D level play a role in COPD?

Cited by 4 publications

References 24 publications

Does vitamin D deficiency worsen the clinical and functional parameters of stable chronic obstructive pulmonary disease patients?

Does vitamin D deficiency worsen the clinical and functional parameters of stable chronic obstructive pulmonary disease patients?

Vitamin D and chronic obstructive pulmonary disease

Chronic Obstructive Pulmonary Disease: A 2019 Evidence Analysis Center Evidence-Based Practice Guideline

Contact Info

Product

Resources

About